The development and utility of a novel scale that quantifies the glycemic progression toward type 1 diabetes over 6 months.
about
HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 Haplotype Protects Autoantibody-Positive Relatives From Type 1 Diabetes Throughout the Stages of Disease ProgressionIncreasing ICA512 autoantibody titers predict development of abnormal oral glucose tolerance tests.Type 1 diabetes in very young children: a model of parent and child influences on management and outcomes.Staging the progression to type 1 diabetes with prediagnostic markersThe Use of Electrochemiluminescence Assays to Predict Autoantibody and Glycemic Progression Toward Type 1 Diabetes in Individuals with Single Autoantibodies.
P2860
The development and utility of a novel scale that quantifies the glycemic progression toward type 1 diabetes over 6 months.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The development and utility of ...... type 1 diabetes over 6 months
@nl
The development and utility of ...... type 1 diabetes over 6 months.
@ast
The development and utility of ...... type 1 diabetes over 6 months.
@en
type
label
The development and utility of ...... type 1 diabetes over 6 months
@nl
The development and utility of ...... type 1 diabetes over 6 months.
@ast
The development and utility of ...... type 1 diabetes over 6 months.
@en
prefLabel
The development and utility of ...... type 1 diabetes over 6 months
@nl
The development and utility of ...... type 1 diabetes over 6 months.
@ast
The development and utility of ...... type 1 diabetes over 6 months.
@en
P2093
P2860
P356
P1433
P1476
The development and utility of ...... type 1 diabetes over 6 months.
@en
P2093
Carla J Greenbaum
Craig A Beam
David Boulware
Della Matheson
Jay M Sosenko
Jay S Skyler
Jeffrey L Mahon
Jeffrey P Krischer
Jerry P Palmer
Kevan C Herold
P2860
P304
P356
10.2337/DC14-2787
P407
P577
2015-03-10T00:00:00Z